Brian Leyland Jones
Medical Oncology · Sioux Falls, SDNPI 1174686547
Payments from drug & device makers
Across 371 payments — averaging $1648.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$198K
- Puma Biotechnology, Inc.$186K
- GSK$160K
- Bayer$49K
- Exelixis Inc.$9K
- Ipsen Biopharmaceuticals, Inc$5K
- plus $4K from 2 others
What the payments were for
- Consulting fees$8,3802%
- Speaking & faculty fees$336,24576%
- Travel & lodging$92,12821%
- Food & beverage$5,7451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 112 | $197,938 |
| Puma Biotechnology, Inc. | 192 | $186,402 |
| GSK | 2 | $159,962 |
| Bayer | 56 | $49,228 |
| Exelixis Inc. | 6 | $8,970 |
| Ipsen Biopharmaceuticals, Inc | 1 | $4,560 |
| Tesaro, Inc. | 1 | $4,000 |
| Roche Molecular Systems, Inc. | 1 | $400 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few medical oncology providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Other medical oncology in Sioux Falls
- David ElsonSioux Falls$15
- Mark SchroederRapid City$203K
- Richard TenglinRapid City$15
- Michael RobinsonRapid City$11
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.